Correlation Between Salesforce and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Salesforce and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Qualigen Therapeutics, you can compare the effects of market volatilities on Salesforce and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Qualigen Therapeutics.
Diversification Opportunities for Salesforce and Qualigen Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Salesforce and Qualigen is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Salesforce and Qualigen Therapeutics
Considering the 90-day investment horizon Salesforce is expected to generate 0.19 times more return on investment than Qualigen Therapeutics. However, Salesforce is 5.17 times less risky than Qualigen Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 26,899 in Salesforce on August 25, 2024 and sell it today you would earn a total of 7,303 from holding Salesforce or generate 27.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Qualigen Therapeutics
Performance |
| Timeline |
| Salesforce |
| Qualigen Therapeutics |
Salesforce and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Qualigen Therapeutics
The main advantage of trading using opposite Salesforce and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |